Sun Addresses FDA Observations At Caraco
  • Prabha Hedge
  • Oct 28 2013

October 28: Sun Pharma has said that it has addressed FDA worries about quality control at its U.S. subsidiary that was shut by the regulator for three years on back of manufacturing flaws. Bloomberg’s Ketaki Gokhale gets you more on this story.